Pharmacological characterization of the ameliorating effect on learning and memory impairment and antinociceptive effect of KT-95 in mice

Behavioural Brain Research

Volumn 167, Issue 2, 2006, Pages 219-225

  Hiramatsu, Masayuki ^a   Mizuno, Natsuko ^a   Kanematsu, Ken ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

Opioid receptor; Receptor; Antinociceptive effect; KT 95; Passive avoidance test; Spontaneous alternation

Indexed keywords

2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; 3 ACETOXY 6 BETA ACETYLTHIO 10 OXO N CYCLOPROPYLMETHYL DIHYDRONORMORPHINE; ANTINOCICEPTIVE AGENT; KAPPA OPIATE RECEPTOR; KT 95; MORPHINE DERIVATIVE; NALOXONE; NORBINALTORPHIMINE; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; DRUG EFFECT; DRUG MECHANISM; ELECTRIC SHOCK; LEARNING; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NOCICEPTION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SHORT TERM MEMORY; WORKING MEMORY; WRITHING TEST;

ANIMALS; AVOIDANCE LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MAZE LEARNING; MEMORY; MICE; MORPHINE DERIVATIVES; MUSCARINIC ANTAGONISTS; NOOTROPIC AGENTS; PAIN THRESHOLD; RECEPTORS, OPIOID, KAPPA; RECEPTORS, SIGMA; SCOPOLAMINE;

EID: 30744464336     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2005.09.009     Document Type: Article

References (20)

1. C.-C. Chien, and G.W. Pasternak Selective antagonism of opioid analgesia by a sigma system J Pharmacol Exp Ther 271 1994 1583 1590
2. T.J. Haley, and W.G. McCormick Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse Br J Pharmacol 12 1957 12 15
3. M. Hiramatsu, and T. Hoshino Improvement of memory impairment by (+)- and (-)-pentazocine via σ, but not κ-opioid receptors Brain Res 1057 2005 72 80
4. M. Hiramatsu, T. Hoshino, T. Kameyama, and T. Nabeshima Involvement of κ-opioid and σ-receptors in short-term memory in mice Eur J Pharmacol 453 2002 91 98
5. M. Hiramatsu, T. Hoshino, and K. Kanematsu Pharmacological characterization of the ameliorating effect on short-term memory impairment and antinociceptive effect of KT-90 in mice Behav Brain Res 160 2005 374 381
6. M. Hiramatsu, T. Hyodo, and T. Kameyama U-50,488H, a selective κ-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice Eur J Pharmacol 315 1996 119 125
7. M. Hiramatsu, H. Murasawa, T. Nabeshima, and T. Kameyama Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats J Pharmacol Exp Ther 284 1998 858 867
8. R. Hosoki, S. Niizawa, K. Koike, T. Sagara, K. Kanematsu, and I. Takayanagi Some pharmacological properties of a newly synthesized 3-acetoxy-6-β-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95) Arch Int Pharmacodyn Ther 331 1996 136 152
9. Q. Jiang, A. Seyed-Mozaffari, A. Sebastian, S. Archer, and J.M. Bidlack Preventing morphine antinociceptive tolerance by irreversible mu opioid antagonists before the onset of their antagonism J Pharmacol Exp Ther 273 1995 680 688
10. K. Kanematsu, T. Yoshiyasu, and M. Yoshida Molecular structure of (-)-3-acetyl-6β-(acetylthio)-N-(cyclopropyl-methyl) normorphine and its 14-hydroxy congeners Chem Pharm Bull 38 1990 1441 1443
11. S. Katsumata, Y. Ienaga, M. Minami, T. Nakagawa, K. Kanematsu, and M. Satoh Pharmacological characterization of KT-90 using cloned μ-, δ- and κ-opioid receptors Eur J Pharmacol 312 1996 349 355
12. K. Matsuno, K. Matsunaga, T. Senda, and S. Mita Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex J Pharmacol Exp Ther 265 1993 851 859
13. K. Matsuno, M. Nakazawa, K. Okamoto, Y. Kawashima, and S. Mita Binding properties of SA4503, a novel and selective σ1-receptor agonist Eur J Pharmacol 306 1996 271 279
14. T. Maurice, M. Hiramatsu, J. Itoh, T. Kameyama, T. Hasegawa, and T. Nabeshima Behavioral evidence for a modulating role of σ-ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia Brain Res 647 1994 44 56
15. M. Sarter, G. Bodewitz, and D.N. Stephens Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist β-carbolines Psychopharmacology 94 1988 491 495
16. T. Senda, K. Matsuno, T. Kobayashi, and S. Mita Reduction of the scopolamine-induced impairment of passive-avoidance performance by σ-receptor agonist in mice Physiol Behav 61 1997 257 264
17. I. Takayanagi, K. Koike, and M. Satoh Interactions of N-cyclopropylmethyl-(-)-6β-acetylthionormorphine with μ-, κ- and δ- and σ-opioid receptors Gen Pharmacol 22 1991 965 967
18. I. Takayanagi, K. Koike, and T. Suzuki Pharmacological properties of newly synthesized derivatives of (-)-6β-acetylthionormorphine and their interactions with opioid receptors Gen Pharmacol 21 1990 605 611
19. F.C. Tortella, and M.A. DeCoster κ-Opioids: therapeutic considerations in epilepsy and CNS injury Clin Neuropharmacol 17 1994 403 416
20. T. Yamamoto, M. Ohno, and S. Ueki A selective κ-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats Eur J Pharmacol 156 1988 173 176